nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyclothiazide—Vasculitis—Vemurafenib—melanoma	0.0355	0.0383	CcSEcCtD
Methyclothiazide—Photosensitivity—Vemurafenib—melanoma	0.0286	0.0309	CcSEcCtD
Methyclothiazide—SLC12A1—appendage—melanoma	0.0243	0.335	CbGeAlD
Methyclothiazide—Photosensitivity reaction—Vemurafenib—melanoma	0.0198	0.0214	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.0192	0.0207	CcSEcCtD
Methyclothiazide—Aplastic anaemia—Dactinomycin—melanoma	0.0184	0.0198	CcSEcCtD
Methyclothiazide—Aplastic anaemia—Temozolomide—melanoma	0.0166	0.0179	CcSEcCtD
Methyclothiazide—Erythema multiforme—Vemurafenib—melanoma	0.0165	0.0177	CcSEcCtD
Methyclothiazide—Malnutrition—Vemurafenib—melanoma	0.0151	0.0163	CcSEcCtD
Methyclothiazide—Vascular purpura—Temozolomide—melanoma	0.0144	0.0155	CcSEcCtD
Methyclothiazide—Purpura—Temozolomide—melanoma	0.0133	0.0144	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Vemurafenib—melanoma	0.0124	0.0133	CcSEcCtD
Methyclothiazide—Pneumonia—Bleomycin—melanoma	0.0118	0.0127	CcSEcCtD
Methyclothiazide—Pneumonia—Dactinomycin—melanoma	0.011	0.0119	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.0109	0.0117	CcSEcCtD
Methyclothiazide—Decreased appetite—Vemurafenib—melanoma	0.0107	0.0116	CcSEcCtD
Methyclothiazide—Constipation—Vemurafenib—melanoma	0.0106	0.0114	CcSEcCtD
Methyclothiazide—Pulmonary oedema—Docetaxel—melanoma	0.0105	0.0113	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Carmustine—melanoma	0.0104	0.0112	CcSEcCtD
Methyclothiazide—Pneumonia—Carmustine—melanoma	0.0103	0.0111	CcSEcCtD
Methyclothiazide—Agranulocytosis—Dactinomycin—melanoma	0.0102	0.011	CcSEcCtD
Methyclothiazide—Photosensitivity reaction—Temozolomide—melanoma	0.0101	0.0109	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Temozolomide—melanoma	0.01	0.0108	CcSEcCtD
Methyclothiazide—Pneumonia—Temozolomide—melanoma	0.00996	0.0107	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Temozolomide—melanoma	0.00982	0.0106	CcSEcCtD
Methyclothiazide—Body temperature increased—Vemurafenib—melanoma	0.00977	0.0105	CcSEcCtD
Methyclothiazide—Erythema multiforme—Dactinomycin—melanoma	0.0093	0.01	CcSEcCtD
Methyclothiazide—Hypersensitivity—Vemurafenib—melanoma	0.00911	0.00982	CcSEcCtD
Methyclothiazide—Asthenia—Vemurafenib—melanoma	0.00887	0.00956	CcSEcCtD
Methyclothiazide—Diarrhoea—Vemurafenib—melanoma	0.00846	0.00912	CcSEcCtD
Methyclothiazide—Erythema multiforme—Temozolomide—melanoma	0.00841	0.00906	CcSEcCtD
Methyclothiazide—Leukopenia—Bleomycin—melanoma	0.00821	0.00886	CcSEcCtD
Methyclothiazide—Dizziness—Vemurafenib—melanoma	0.00817	0.00881	CcSEcCtD
Methyclothiazide—Malnutrition—Carmustine—melanoma	0.00801	0.00864	CcSEcCtD
Methyclothiazide—Vomiting—Vemurafenib—melanoma	0.00786	0.00847	CcSEcCtD
Methyclothiazide—Orthostatic hypotension—Docetaxel—melanoma	0.00781	0.00842	CcSEcCtD
Methyclothiazide—Rash—Vemurafenib—melanoma	0.00779	0.0084	CcSEcCtD
Methyclothiazide—Dermatitis—Vemurafenib—melanoma	0.00779	0.0084	CcSEcCtD
Methyclothiazide—Headache—Vemurafenib—melanoma	0.00774	0.00835	CcSEcCtD
Methyclothiazide—Malnutrition—Temozolomide—melanoma	0.00774	0.00835	CcSEcCtD
Methyclothiazide—Cramp muscle—Docetaxel—melanoma	0.0077	0.0083	CcSEcCtD
Methyclothiazide—Leukopenia—Dactinomycin—melanoma	0.00766	0.00826	CcSEcCtD
Methyclothiazide—Vision blurred—Carmustine—melanoma	0.00755	0.00814	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Bleomycin—melanoma	0.00749	0.00807	CcSEcCtD
Methyclothiazide—Agitation—Carmustine—melanoma	0.00736	0.00794	CcSEcCtD
Methyclothiazide—Nausea—Vemurafenib—melanoma	0.00734	0.00792	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Bleomycin—melanoma	0.00733	0.00791	CcSEcCtD
Methyclothiazide—Vision blurred—Temozolomide—melanoma	0.00729	0.00787	CcSEcCtD
Methyclothiazide—Leukopenia—Carmustine—melanoma	0.00717	0.00773	CcSEcCtD
Methyclothiazide—Anorexia—Bleomycin—melanoma	0.00714	0.0077	CcSEcCtD
Methyclothiazide—Agitation—Temozolomide—melanoma	0.00711	0.00767	CcSEcCtD
Methyclothiazide—Vertigo—Temozolomide—melanoma	0.00695	0.0075	CcSEcCtD
Methyclothiazide—Leukopenia—Temozolomide—melanoma	0.00693	0.00747	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Dactinomycin—melanoma	0.00684	0.00737	CcSEcCtD
Methyclothiazide—Paraesthesia—Bleomycin—melanoma	0.00672	0.00725	CcSEcCtD
Methyclothiazide—Anorexia—Dactinomycin—melanoma	0.00666	0.00718	CcSEcCtD
Methyclothiazide—Pneumonia—Docetaxel—melanoma	0.00663	0.00714	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Docetaxel—melanoma	0.00653	0.00704	CcSEcCtD
Methyclothiazide—Decreased appetite—Bleomycin—melanoma	0.00651	0.00702	CcSEcCtD
Methyclothiazide—CA2—hair follicle—melanoma	0.00642	0.0886	CbGeAlD
Methyclothiazide—Jaundice—Docetaxel—melanoma	0.00642	0.00692	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Carmustine—melanoma	0.0064	0.0069	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Temozolomide—melanoma	0.00632	0.00681	CcSEcCtD
Methyclothiazide—Anorexia—Carmustine—melanoma	0.00623	0.00672	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Temozolomide—melanoma	0.00619	0.00667	CcSEcCtD
Methyclothiazide—Agranulocytosis—Docetaxel—melanoma	0.00615	0.00663	CcSEcCtD
Methyclothiazide—Decreased appetite—Dactinomycin—melanoma	0.00607	0.00655	CcSEcCtD
Methyclothiazide—Anorexia—Temozolomide—melanoma	0.00602	0.00649	CcSEcCtD
Methyclothiazide—Urticaria—Bleomycin—melanoma	0.00595	0.00641	CcSEcCtD
Methyclothiazide—Body temperature increased—Bleomycin—melanoma	0.00592	0.00638	CcSEcCtD
Methyclothiazide—Paraesthesia—Carmustine—melanoma	0.00587	0.00633	CcSEcCtD
Methyclothiazide—Decreased appetite—Carmustine—melanoma	0.00568	0.00613	CcSEcCtD
Methyclothiazide—Paraesthesia—Temozolomide—melanoma	0.00567	0.00612	CcSEcCtD
Methyclothiazide—Erythema multiforme—Docetaxel—melanoma	0.00559	0.00603	CcSEcCtD
Methyclothiazide—Constipation—Carmustine—melanoma	0.00559	0.00603	CcSEcCtD
Methyclothiazide—Body temperature increased—Dactinomycin—melanoma	0.00552	0.00595	CcSEcCtD
Methyclothiazide—Hypersensitivity—Bleomycin—melanoma	0.00552	0.00595	CcSEcCtD
Methyclothiazide—Decreased appetite—Temozolomide—melanoma	0.00549	0.00592	CcSEcCtD
Methyclothiazide—Constipation—Temozolomide—melanoma	0.0054	0.00582	CcSEcCtD
Methyclothiazide—Asthenia—Bleomycin—melanoma	0.00537	0.00579	CcSEcCtD
Methyclothiazide—CA4—neck—melanoma	0.0052	0.0717	CbGeAlD
Methyclothiazide—Body temperature increased—Carmustine—melanoma	0.00517	0.00557	CcSEcCtD
Methyclothiazide—Malnutrition—Docetaxel—melanoma	0.00515	0.00555	CcSEcCtD
Methyclothiazide—Hypersensitivity—Dactinomycin—melanoma	0.00515	0.00555	CcSEcCtD
Methyclothiazide—Urticaria—Temozolomide—melanoma	0.00502	0.00541	CcSEcCtD
Methyclothiazide—Asthenia—Dactinomycin—melanoma	0.00501	0.0054	CcSEcCtD
Methyclothiazide—Body temperature increased—Temozolomide—melanoma	0.00499	0.00538	CcSEcCtD
Methyclothiazide—Muscle spasms—Docetaxel—melanoma	0.00495	0.00534	CcSEcCtD
Methyclothiazide—CA1—eye—melanoma	0.00495	0.0682	CbGeAlD
Methyclothiazide—Hypersensitivity—Carmustine—melanoma	0.00482	0.00519	CcSEcCtD
Methyclothiazide—Diarrhoea—Dactinomycin—melanoma	0.00478	0.00515	CcSEcCtD
Methyclothiazide—Vomiting—Bleomycin—melanoma	0.00476	0.00513	CcSEcCtD
Methyclothiazide—Rash—Bleomycin—melanoma	0.00472	0.00509	CcSEcCtD
Methyclothiazide—Dermatitis—Bleomycin—melanoma	0.00472	0.00509	CcSEcCtD
Methyclothiazide—Asthenia—Carmustine—melanoma	0.00469	0.00506	CcSEcCtD
Methyclothiazide—Hypersensitivity—Temozolomide—melanoma	0.00465	0.00502	CcSEcCtD
Methyclothiazide—Leukopenia—Docetaxel—melanoma	0.00461	0.00497	CcSEcCtD
Methyclothiazide—Asthenia—Temozolomide—melanoma	0.00453	0.00489	CcSEcCtD
Methyclothiazide—Diarrhoea—Carmustine—melanoma	0.00447	0.00482	CcSEcCtD
Methyclothiazide—Nausea—Bleomycin—melanoma	0.00445	0.0048	CcSEcCtD
Methyclothiazide—Vomiting—Dactinomycin—melanoma	0.00444	0.00479	CcSEcCtD
Methyclothiazide—Rash—Dactinomycin—melanoma	0.0044	0.00475	CcSEcCtD
Methyclothiazide—Dizziness—Carmustine—melanoma	0.00432	0.00466	CcSEcCtD
Methyclothiazide—Diarrhoea—Temozolomide—melanoma	0.00432	0.00466	CcSEcCtD
Methyclothiazide—CA2—neck—melanoma	0.00431	0.0594	CbGeAlD
Methyclothiazide—Anaphylactic shock—Docetaxel—melanoma	0.0042	0.00453	CcSEcCtD
Methyclothiazide—Dizziness—Temozolomide—melanoma	0.00418	0.0045	CcSEcCtD
Methyclothiazide—Vomiting—Carmustine—melanoma	0.00416	0.00448	CcSEcCtD
Methyclothiazide—Nausea—Dactinomycin—melanoma	0.00415	0.00447	CcSEcCtD
Methyclothiazide—Rash—Carmustine—melanoma	0.00412	0.00444	CcSEcCtD
Methyclothiazide—Dermatitis—Carmustine—melanoma	0.00412	0.00444	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Docetaxel—melanoma	0.00411	0.00443	CcSEcCtD
Methyclothiazide—Headache—Carmustine—melanoma	0.0041	0.00442	CcSEcCtD
Methyclothiazide—SLC12A1—head—melanoma	0.00408	0.0563	CbGeAlD
Methyclothiazide—Vomiting—Temozolomide—melanoma	0.00402	0.00433	CcSEcCtD
Methyclothiazide—Anorexia—Docetaxel—melanoma	0.004	0.00432	CcSEcCtD
Methyclothiazide—Rash—Temozolomide—melanoma	0.00398	0.00429	CcSEcCtD
Methyclothiazide—Dermatitis—Temozolomide—melanoma	0.00398	0.00429	CcSEcCtD
Methyclothiazide—Headache—Temozolomide—melanoma	0.00396	0.00427	CcSEcCtD
Methyclothiazide—Nausea—Carmustine—melanoma	0.00388	0.00419	CcSEcCtD
Methyclothiazide—Paraesthesia—Docetaxel—melanoma	0.00377	0.00407	CcSEcCtD
Methyclothiazide—Nausea—Temozolomide—melanoma	0.00375	0.00405	CcSEcCtD
Methyclothiazide—Decreased appetite—Docetaxel—melanoma	0.00365	0.00394	CcSEcCtD
Methyclothiazide—Constipation—Docetaxel—melanoma	0.00359	0.00387	CcSEcCtD
Methyclothiazide—Body temperature increased—Docetaxel—melanoma	0.00332	0.00358	CcSEcCtD
Methyclothiazide—CA2—eye—melanoma	0.00321	0.0442	CbGeAlD
Methyclothiazide—CA2—retina—melanoma	0.00318	0.0438	CbGeAlD
Methyclothiazide—Hypersensitivity—Docetaxel—melanoma	0.0031	0.00334	CcSEcCtD
Methyclothiazide—Asthenia—Docetaxel—melanoma	0.00301	0.00325	CcSEcCtD
Methyclothiazide—Diarrhoea—Docetaxel—melanoma	0.00287	0.0031	CcSEcCtD
Methyclothiazide—CA1—head—melanoma	0.00281	0.0387	CbGeAlD
Methyclothiazide—CA2—skin of body—melanoma	0.00279	0.0385	CbGeAlD
Methyclothiazide—Dizziness—Docetaxel—melanoma	0.00278	0.003	CcSEcCtD
Methyclothiazide—Vomiting—Docetaxel—melanoma	0.00267	0.00288	CcSEcCtD
Methyclothiazide—Rash—Docetaxel—melanoma	0.00265	0.00286	CcSEcCtD
Methyclothiazide—Dermatitis—Docetaxel—melanoma	0.00265	0.00285	CcSEcCtD
Methyclothiazide—Headache—Docetaxel—melanoma	0.00263	0.00284	CcSEcCtD
Methyclothiazide—CA2—mammalian vulva—melanoma	0.00254	0.0351	CbGeAlD
Methyclothiazide—Nausea—Docetaxel—melanoma	0.0025	0.00269	CcSEcCtD
Methyclothiazide—CA4—head—melanoma	0.00219	0.0303	CbGeAlD
Methyclothiazide—CA1—lymph node—melanoma	0.00197	0.0271	CbGeAlD
Methyclothiazide—CA2—head—melanoma	0.00182	0.0251	CbGeAlD
Methyclothiazide—CA4—lymph node—melanoma	0.00154	0.0212	CbGeAlD
Methyclothiazide—CA2—lymph node—melanoma	0.00127	0.0176	CbGeAlD
